Advances in Hematology

Open accessIn DOAJFee waivers availableMedicine

Advances in Hematology is published by Hindawi Publishing Corporation as an open access journal (ISSN 1687-9104). The list article processing charge is $860. Typical time to publication is 15 wks. Its OpenAlex h-index is 49. Primary field: Medicine. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$860

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

15 wks

Broadly typical for the field.

h-index

49

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

1.3

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Advances in Hematology is listed at $860. The publisher also lists 740 EUR, 640 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Advances in Hematology, as recorded by OpenAlex for each year. The fee has risen 8% since 2023, from $800 to $860.

$0$430$8602023: $80020232024: $82020242025: $8602025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY
Author keeps copyrightYes
Plagiarism screeningYes
Editorial boardPublished →
LanguagesEN

Verification checks

8 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.Confirmed
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
  • Peer review model publicly declaredAnonymous peer reviewConfirmed
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Confirmed
  • Screens submissions for plagiarismReported to DOAJ by the journal.Confirmed
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Confirmed
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Confirmed
  • Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Advances in Hematology publishes most, derived from the topics assigned to its indexed articles.

Hemoglobinopathies and Related DisordersLymphoma Diagnosis and TreatmentIron Metabolism and DisordersChronic Lymphocytic Leukemia ResearchBlood groups and transfusionAcute Myeloid Leukemia ResearchMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchViral-associated cancers and disordersChronic Myeloid Leukemia Treatments

Publication record

Indexed articles412
Total citations8,651
i10-index225
Most recent indexed article2026
Open access since2009
All ISSNs1687-9104, 1687-9112

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.